Friday, July 31, 2026

Stars Under the Stars: KBO All-Star Game Brings Baseball Magic Despite Rain Forecast

Despite the weather forecast predicting rain, the...

Neurophet Partners with ALZ-NET: Revolutionizing Alzheimer’s Diagnosis with AI Technology

Neurophet partners with ALZ-NET to enhance Alzheimer's care through advanced AI solutions and imaging monitoring for better patient outcomes.

Human Rights Commission Reviews Possible Statement on Two North Korean POWs Held in Ukraine

The NHRC of Korea is reviewing a statement urging the government to aid in the return of two North Korean POWs held in Ukraine.

Tag: immuno-oncology

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

ABL Bio to Launch Global Phase 3 Trial of Gastric Cancer Drug Givastomig This Year at BIO USA

ABL Bio plans a Phase 3 trial for gastric cancer therapy Givastomig, targeting a $2.5 billion market opportunity.

CT-P72/ABP-102: The Next Big Breakthrough in HER2 Cancer Treatment?

Celltrion's CT-P72/ABP-102 shows strong efficacy against HER2 tumors, promising for treating various cancers with reduced toxicity.

AACR 2026 Highlighted Shift Toward Patient-Centered Cancer Drug Development, Foundation Says

Cancer research is evolving towards patient-centered outcomes, integrating data and technology for better treatments, as noted at AACR 2026.

GI-101A: Breakthrough Immuno-Oncology Drug Set for ASCO 2026 Presentation

GI Innovation's GI-101A will be presented at ASCO 2026, highlighting its clinical potential and significance in oncology.

How Celltrion Plans to Cut Biologics Development Costs by 25% Amid FDA Regulation Changes

Celltrion is optimistic about enhanced competitiveness due to eased biosimilar regulations by the FDA, expecting significant cost reductions.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.